Metsera to accept Pfizer after call from US antitrust regulators
MLex Summary: Pfizer is on track to buy Metsera, after the target's board recommended its offer over a rival, equal bid by Novo Nordisk. The board said it had received a...To view the full article, register now.
Already a subscriber? Click here to view full article